Impact BioMedical Inc.

AMEX: IBO · Real-Time Price · USD
0.58
0.01 (2.29%)
At close: Aug 15, 2025, 3:59 PM
0.56
-2.75%
After-hours: Aug 15, 2025, 07:32 PM EDT

Impact BioMedical Cash Flow Statement

Financials in CAD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-1.82K -27.13M 4.24M -882K -998K -1.26M -1.58K -1.46K -486.6K -792.86K -841.96K -6.55M -1.17M -1.04M -1.73M -23.16K -83.42K
Depreciation & Amortization
407.20 279K 281K 279K 280K 280K 380.31 370.92 72.31K 69.43K 66.33K 79.16K 71.57K 68.94K 46.72K 77.00 76.00
Stock-Based Compensation
n/a n/a n/a n/a n/a n/a n/a n/a 25.7K -2.6K 97.58K 121.95K 40.08K -47.11K 788.62K n/a n/a
Other Working Capital
156.84 193K -282K -26K -185K 192K -58.4 113.93 n/a n/a n/a n/a n/a n/a n/a 6.69K 74.52K
Other Non-Cash Items
277.70 26.01M -5.67M -230K 230K n/a 217.32 128.50 17.32K 27.32K n/a 2.63M -25 -85 160.48K n/a n/a
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a 210K n/a 2.71M n/a n/a 25.00 n/a n/a
Change in Working Capital
156.84 -412K -139K -63K 6K 548K 69.27 -10.6 199.11K 8.11K 227.62K -702.36K 297K -98.12K -4.23K 13.85K 70.23K
Operating Cash Flow
-981 -1.26M -1.28M -896K -482K -433K -911 -971 -172.15K -480.6K -450.43K -1.71M -765.03K -1.12M -739.6K -9.23K -13.12K
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a -15.9 -42.74K -210.79K -143.24K -11.77K -83.91K n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 618.01K n/a n/a -2.67M n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a 1K 1K n/a 1K n/a n/a n/a n/a n/a n/a n/a n/a 42.93K n/a n/a
Investing Cash Flow
n/a n/a 1K 1K n/a 1K n/a -14.57 -42.74K -210.79K -143.24K 606.25K -83.91K 11.86K -2.62M n/a n/a
Debt Repayment
n/a 587K 224K 895K 483K 232K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 3.73M n/a n/a n/a 1.18K 988.25 380K 182.25K 583.22K -21.89K -21.85K -10.99K 1.34M 2.87M 2.03M
Financial Cash Flow
n/a 587K 3.95M 895K 483K 232K 1.18K 988.25 375.93K 179.71K 571.3K -121.89K -271.85K -10.99K 7.41M 2.87M 2.13M
Net Cash Flow
-977 -669K 2.67M n/a 1K -200K 269.03 n/a 161.05K -511.67K -22.37K -1.23M -1.12M -1.12M 4.05M 2.86M 2.12M
Free Cash Flow
-981 -1.26M -1.28M -896K -482K -433K -912 -986 -214.89K -691.38K -593.67K -1.72M -848.94K -1.12M -739.6K -9.23K -13.12K